{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,11,3]],"date-time":"2026-11-03T10:22:35Z","timestamp":1793701355143,"version":"4.5.1"},"reference-count":47,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T00:00:00Z","timestamp":1642636800000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springer.com\/tdm"}],"funder":[{"name":"the netherlands organisation for scientific research","award":["No.91719300"],"award-info":[{"award-number":["No.91719300"]}]},{"name":"the dutch cancer society for funding a dutch cancer society young investigator grant","award":["10140"],"award-info":[{"award-number":["10140"]}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["J Mol Med"],"published-print":{"date-parts":[[2022,3]]},"DOI":"10.1007\/s00109-021-02176-x","type":"journal-article","created":{"date-parts":[[2022,1,20]],"date-time":"2022-01-20T19:03:36Z","timestamp":1642705416000},"page":"471-484","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":31,"title":["Recapitulating lipid accumulation and related metabolic dysregulation in human liver-derived organoids"],"prefix":"10.1007","volume":"100","author":[{"given":"Ling","family":"Wang","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meng","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Bingting","family":"Yu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Shaojun","family":"Shi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiaye","family":"Liu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruyi","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ibrahim","family":"Ayada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Monique M. A.","family":"Verstegen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Luc J. W.","family":"van der Laan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Maikel P.","family":"Peppelenbosch","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Wanlu","family":"Cao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-9982-6184","authenticated-orcid":false,"given":"Qiuwei","family":"Pan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2022,1,20]]},"reference":[{"key":"2176_CR1","doi-asserted-by":"publisher","first-page":"274","DOI":"10.1111\/j.1365-2036.2011.04724.x","volume":"34","author":"G Vernon","year":"2011","unstructured":"Vernon G, Baranova A, Younossi ZM (2011) Systematic review: the epidemiology and natural history of non-alcoholic fatty liver disease and non-alcoholic steatohepatitis in adults. Aliment Pharmacol Ther 34:274\u2013285. https:\/\/doi.org\/10.1111\/j.1365-2036.2011.04724.x","journal-title":"Aliment Pharmacol Ther"},{"key":"2176_CR2","doi-asserted-by":"publisher","first-page":"202","DOI":"10.1016\/j.jhep.2020.03.039","volume":"73","author":"M Eslam","year":"2020","unstructured":"Eslam M, Newsome PN, Sarin SK, Anstee QM, Targher G, Romero-Gomez M, Zelber-Sagi S, Wong VWS, Dufour J-F, Schattenberg JM et al (2020) A new definition for metabolic dysfunction-associated fatty liver disease: an international expert consensus statement. J Hepatol 73:202\u2013209. https:\/\/doi.org\/10.1016\/j.jhep.2020.03.039","journal-title":"J Hepatol"},{"key":"2176_CR3","doi-asserted-by":"publisher","DOI":"10.1016\/j.biocel.2021.105937","volume":"133","author":"L Wang","year":"2021","unstructured":"Wang L, Liu J, Miao Z, Pan Q, Cao W (2021) Lipid droplets and their interactions with other organelles in liver diseases. Int J Biochem Cell Biol 133:105937. https:\/\/doi.org\/10.1016\/j.biocel.2021.105937","journal-title":"Int J Biochem Cell Biol"},{"key":"2176_CR4","doi-asserted-by":"publisher","first-page":"4701","DOI":"10.1038\/s41598-020-61473-6","volume":"10","author":"P Yang","year":"2020","unstructured":"Yang P, Wang Y, Tang W, Sun W, Ma Y, Lin S, Jing J, Jiang L, Shi H, Song Z et al (2020) Western diet induces severe nonalcoholic steatohepatitis, ductular reaction, and hepatic fibrosis in liver CGI-58 knockout mice. Sci Rep 10:4701. https:\/\/doi.org\/10.1038\/s41598-020-61473-6","journal-title":"Sci Rep"},{"key":"2176_CR5","doi-asserted-by":"publisher","first-page":"114","DOI":"10.1186\/s12944-016-0283-7","volume":"15","author":"KA Lockman","year":"2016","unstructured":"Lockman KA, Htun V, Sinha R, Treskes P, Nelson LJ, Martin SF, Rogers SM, Le Bihan T, Hayes PC, Plevris JN (2016) Proteomic profiling of cellular steatosis with concomitant oxidative stress in vitro. Lipids Health Dis 15:114. https:\/\/doi.org\/10.1186\/s12944-016-0283-7","journal-title":"Lipids Health Dis"},{"key":"2176_CR6","doi-asserted-by":"publisher","first-page":"3574","DOI":"10.1038\/s41467-019-11415-2","volume":"10","author":"K Yu","year":"2019","unstructured":"Yu K, Chen B, Aran D, Charalel J, Yau C, Wolf DM, van\u2019t Veer LJ, Butte AJ, Goldstein T, Sirota M (2019) Comprehensive transcriptomic analysis of cell lines as models of primary tumors across 22 tumor types. Nat Commun 10:3574. https:\/\/doi.org\/10.1038\/s41467-019-11415-2","journal-title":"Nat Commun"},{"key":"2176_CR7","doi-asserted-by":"publisher","first-page":"374","DOI":"10.1016\/j.cmet.2019.05.007","volume":"30","author":"R Ouchi","year":"2019","unstructured":"Ouchi R, Togo S, Kimura M, Shinozawa T, Koido M, Koike H, Thompson W, Karns RA, Mayhew CN, McGrath PS et al (2019) Modeling steatohepatitis in humans with pluripotent stem cell-derived organoids. Cell Metab 30:374\u2013384. https:\/\/doi.org\/10.1016\/j.cmet.2019.05.007","journal-title":"Cell Metab"},{"key":"2176_CR8","doi-asserted-by":"publisher","first-page":"1471","DOI":"10.1053\/j.gastro.2020.06.010","volume":"159","author":"MNB Ramli","year":"2020","unstructured":"Ramli MNB, Lim YS, Koe CT, Demircioglu D, Tng W, Gonzales KAU, Tan CP, Szczerbinska I, Liang H, Soe EL et al (2020) Human pluripotent stem cell-derived organoids as models of liver disease. Gastroenterology 159:1471\u20131486. https:\/\/doi.org\/10.1053\/j.gastro.2020.06.010","journal-title":"Gastroenterology"},{"key":"2176_CR9","doi-asserted-by":"publisher","first-page":"393","DOI":"10.1016\/j.molmed.2017.02.007","volume":"23","author":"D Dutta","year":"2017","unstructured":"Dutta D, Heo I, Clevers H (2017) Disease modeling in stem cell-derived 3D organoid systems. Trends Mol Med 23:393\u2013410. https:\/\/doi.org\/10.1016\/j.molmed.2017.02.007","journal-title":"Trends Mol Med"},{"key":"2176_CR10","doi-asserted-by":"publisher","first-page":"299","DOI":"10.1016\/j.cell.2014.11.050","volume":"160","author":"M Huch","year":"2015","unstructured":"Huch M, Gehart H, van Boxtel R, Hamer K, Blokzijl F, Verstegen Monique MA, Ellis E, van Wenum M, Fuchs Sabine A, de Ligt J et al (2015) Long-term culture of genome-stable bipotent stem cells from adult human liver. Cell 160:299\u2013312. https:\/\/doi.org\/10.1016\/j.cell.2014.11.050","journal-title":"Cell"},{"key":"2176_CR11","doi-asserted-by":"publisher","first-page":"1133","DOI":"10.1053\/j.gastro.2017.07.006","volume":"153","author":"W Cao","year":"2017","unstructured":"Cao W, Chen K, Bolkestein M, Yin Y, Verstegen MMA, Bijvelds MJC, Wang W, Tuysuz N, ten Berge D, Sprengers D et al (2017) Dynamics of Proliferative and Quiescent Stem Cells in Liver Homeostasis and Injury. Gastroenterology 153:1133\u20131147. https:\/\/doi.org\/10.1053\/j.gastro.2017.07.006","journal-title":"Gastroenterology"},{"key":"2176_CR12","doi-asserted-by":"publisher","first-page":"21900","DOI":"10.1038\/s41598-020-79082-8","volume":"10","author":"MMA Verstegen","year":"2020","unstructured":"Verstegen MMA, Roos FJM, Burka K, Gehart H, Jager M, de Wolf M, Bijvelds MJC, de Jonge HR, Ardisasmita AI, van Huizen NA et al (2020) Human extrahepatic and intrahepatic cholangiocyte organoids show region-specific differentiation potential and model cystic fibrosis-related bile duct disease. Sci Rep 10:21900. https:\/\/doi.org\/10.1038\/s41598-020-79082-8","journal-title":"Sci Rep"},{"key":"2176_CR13","doi-asserted-by":"publisher","first-page":"816","DOI":"10.1016\/j.stem.2021.04.005","volume":"28","author":"A Marsee","year":"2021","unstructured":"Marsee A, Roos FJM, Verstegen MMA, Marsee A, Roos F, Verstegen M, Clevers H, Vallier L, Takebe T, Huch M et al (2021) Building consensus on definition and nomenclature of hepatic, pancreatic, and biliary organoids. Cell Stem Cell 28:816\u2013832. https:\/\/doi.org\/10.1016\/j.stem.2021.04.005","journal-title":"Cell Stem Cell"},{"key":"2176_CR14","doi-asserted-by":"publisher","first-page":"1591","DOI":"10.1016\/j.cell.2018.11.013","volume":"175","author":"H Hu","year":"2018","unstructured":"Hu H, Gehart H, Artegiani B, L\u00f6pez-Iglesias C, Dekkers F, Basak O, van Es J, de Sousa Lopes SMC, Begthel H, Korving J et al (2018) Long-term expansion of functional mouse and human hepatocytes as 3D organoids. Cell 175:1591\u20131606. https:\/\/doi.org\/10.1016\/j.cell.2018.11.013","journal-title":"Cell"},{"key":"2176_CR15","doi-asserted-by":"publisher","first-page":"1724","DOI":"10.1038\/nprot.2016.097","volume":"11","author":"L Broutier","year":"2016","unstructured":"Broutier L, Andersson-Rolf A, Hindley CJ, Boj SF, Clevers H, Koo B-K, Huch M (2016) Culture and establishment of self-renewing human and mouse adult liver and pancreas 3D organoids and their genetic manipulation. Nat Protoc 11:1724\u20131743. https:\/\/doi.org\/10.1038\/nprot.2016.097","journal-title":"Nat Protoc"},{"key":"2176_CR16","doi-asserted-by":"publisher","first-page":"20170362","DOI":"10.1098\/rstb.2017.0362","volume":"373","author":"MJ Lyall","year":"2018","unstructured":"Lyall MJ, Cartier J, Thomson JP, Cameron K, Meseguer-Ripolles J, O\u2019Duibhir E, Szkolnicka D, Villarin BL, Wang Y, Blanco GR et al (2018) Modelling non-alcoholic fatty liver disease in human hepatocyte-like cells. Philos Trans R Soc Lond B Biol Sci 373:20170362. https:\/\/doi.org\/10.1098\/rstb.2017.0362","journal-title":"Philos Trans R Soc Lond B Biol Sci"},{"key":"2176_CR17","doi-asserted-by":"publisher","first-page":"1366","DOI":"10.1002\/hep.21655","volume":"45","author":"K Yamaguchi","year":"2007","unstructured":"Yamaguchi K, Yang L, McCall S, Huang J, Yu XX, Pandey SK, Bhanot S, Monia BP, Li Y-X, Diehl AM (2007) Inhibiting triglyceride synthesis improves hepatic steatosis but exacerbates liver damage and fibrosis in obese mice with nonalcoholic steatohepatitis. Hepatology 45:1366\u20131374. https:\/\/doi.org\/10.1002\/hep.21655","journal-title":"Hepatology"},{"key":"2176_CR18","doi-asserted-by":"publisher","first-page":"G462","DOI":"10.1152\/ajpgi.00358.2018","volume":"316","author":"MP Suppli","year":"2019","unstructured":"Suppli MP, Rigbolt KTG, Veidal SS, Heeb\u00f8ll S, Eriksen PL, Demant M, Bagger JI, Nielsen JC, Or\u00f3 D, Thrane SW et al (2019) Hepatic transcriptome signatures in patients with varying degrees of nonalcoholic fatty liver disease compared with healthy normal-weight individuals. Am J Physiol Gastrointest Liver Physiol 316:G462\u2013G472. https:\/\/doi.org\/10.1152\/ajpgi.00358.2018","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2176_CR19","doi-asserted-by":"publisher","first-page":"727","DOI":"10.1016\/j.jhep.2009.11.030","volume":"52","author":"RS Rector","year":"2010","unstructured":"Rector RS, Thyfault JP, Uptergrove GM, Morris EM, Naples SP, Borengasser SJ, Mikus CR, Laye MJ, Laughlin MH, Booth FW et al (2010) Mitochondrial dysfunction precedes insulin resistance and hepatic steatosis and contributes to the natural history of non-alcoholic fatty liver disease in an obese rodent model. J Hepatol 52:727\u2013736. https:\/\/doi.org\/10.1016\/j.jhep.2009.11.030","journal-title":"J Hepatol"},{"key":"2176_CR20","doi-asserted-by":"publisher","first-page":"G400","DOI":"10.1152\/ajpgi.00121.2020","volume":"319","author":"W Dornas","year":"2020","unstructured":"Dornas W, Schuppan D (2020) Mitochondrial oxidative injury: a key player in nonalcoholic fatty liver disease. Am J Physiol Gastrointest Liver Physiol 319:G400\u2013G411. https:\/\/doi.org\/10.1152\/ajpgi.00121.2020","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"2176_CR21","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1038\/aps.2014.116","volume":"36","author":"Y Jiao","year":"2015","unstructured":"Jiao Y, Lu Y, Li X-Y (2015) Farnesoid X receptor: a master regulator of hepatic triglyceride and glucose homeostasis. Acta Pharmacol Sin 36:44\u201350. https:\/\/doi.org\/10.1038\/aps.2014.116","journal-title":"Acta Pharmacol Sin"},{"key":"2176_CR22","doi-asserted-by":"publisher","first-page":"2054","DOI":"10.1016\/j.bbadis.2016.07.012","volume":"1862","author":"MC de Oliveira","year":"2016","unstructured":"de Oliveira MC, Gilglioni EH, de Boer BA, Runge JH, de Waart DR, Salgueiro CL, Ishii-Iwamoto EL, Oude Elferink RPJ, Gaemers IC (2016) Bile acid receptor agonists INT747 and INT777 decrease oestrogen deficiency-related postmenopausal obesity and hepatic steatosis in mice. Biochim Biophys Acta Mol Basis Dis 1862:2054\u20132062. https:\/\/doi.org\/10.1016\/j.bbadis.2016.07.012","journal-title":"Biochim Biophys Acta Mol Basis Dis"},{"key":"2176_CR23","doi-asserted-by":"publisher","first-page":"6668","DOI":"10.1038\/s41598-019-43228-0","volume":"9","author":"A Brandt","year":"2019","unstructured":"Brandt A, Hern\u00e1ndez-Arriaga A, Kehm R, S\u00e1nchez V, Jin CJ, Nier A, Baumann A, Camarinha-Silva A, Bergheim I (2019) Metformin attenuates the onset of non-alcoholic fatty liver disease and affects intestinal microbiota and barrier in small intestine. Sci Rep 9:6668. https:\/\/doi.org\/10.1038\/s41598-019-43228-0","journal-title":"Sci Rep"},{"key":"2176_CR24","doi-asserted-by":"publisher","first-page":"2286","DOI":"10.1002\/hep.26939","volume":"59","author":"L Verbeke","year":"2014","unstructured":"Verbeke L, Farre R, Trebicka J, Komuta M, Roskams T, Klein S, Elst IV, Windmolders P, Vanuytsel T, Nevens F et al (2014) Obeticholic acid, a farnesoid X receptor agonist, improves portal hypertension by two distinct pathways in cirrhotic rats. Hepatology 59:2286\u20132298. https:\/\/doi.org\/10.1002\/hep.26939","journal-title":"Hepatology"},{"key":"2176_CR25","doi-asserted-by":"publisher","first-page":"439","DOI":"10.1007\/s40262-015-0323-x","volume":"55","author":"F Kajbaf","year":"2016","unstructured":"Kajbaf F, De Broe ME, Lalau J-D (2016) Therapeutic concentrations of metformin: a systematic review. Clin Pharmacokinet 55:439\u2013459. https:\/\/doi.org\/10.1007\/s40262-015-0323-x","journal-title":"Clin Pharmacokinet"},{"key":"2176_CR26","doi-asserted-by":"publisher","first-page":"401","DOI":"10.1159\/000381643","volume":"24","author":"M Kinaan","year":"2015","unstructured":"Kinaan M, Ding H, Triggle CR (2015) Metformin: an old drug for the treatment of diabetes but a new drug for the protection of the endothelium. Med Princ Pract 24:401\u2013415. https:\/\/doi.org\/10.1159\/000381643","journal-title":"Med Princ Pract"},{"key":"2176_CR27","doi-asserted-by":"publisher","first-page":"106","DOI":"10.1016\/j.cbi.2006.11.004","volume":"165","author":"MJ G\u00f3mez-Lech\u00f3n","year":"2007","unstructured":"G\u00f3mez-Lech\u00f3n MJ, Donato MT, Mart\u00ednez-Romero A, Jim\u00e9nez N, Castell JV, O\u2019Connor J-E (2007) A human hepatocellular in vitro model to investigate steatosis. Chem Biol Interact 165:106\u2013116. https:\/\/doi.org\/10.1016\/j.cbi.2006.11.004","journal-title":"Chem Biol Interact"},{"key":"2176_CR28","doi-asserted-by":"publisher","first-page":"40","DOI":"10.1016\/j.taap.2015.12.020","volume":"292","author":"A Michaut","year":"2016","unstructured":"Michaut A, Le Guillou D, Moreau C, Bucher S, McGill MR, Martinais S, Gicquel T, Morel I, Robin M-A, Jaeschke H et al (2016) A cellular model to study drug-induced liver injury in nonalcoholic fatty liver disease: Application to acetaminophen. Toxicol Appl Pharmacol 292:40\u201355. https:\/\/doi.org\/10.1016\/j.taap.2015.12.020","journal-title":"Toxicol Appl Pharmacol"},{"key":"2176_CR29","doi-asserted-by":"publisher","first-page":"e0170591","DOI":"10.1371\/journal.pone.0170591","volume":"12","author":"I Takahara","year":"2017","unstructured":"Takahara I, Akazawa Y, Tabuchi M, Matsuda K, Miyaaki H, Kido Y, Kanda Y, Taura N, Ohnita K, Takeshima F et al (2017) Toyocamycin attenuates free fatty acid-induced hepatic steatosis and apoptosis in cultured hepatocytes and ameliorates nonalcoholic fatty liver disease in mice. PLoS One 12:e0170591. https:\/\/doi.org\/10.1371\/journal.pone.0170591","journal-title":"PLOS ONE"},{"key":"2176_CR30","doi-asserted-by":"publisher","first-page":"1119","DOI":"10.1089\/scd.2015.0383","volume":"25","author":"N Graffmann","year":"2016","unstructured":"Graffmann N, Ring S, Kawala M-A, Wruck W, Ncube A, Trompeter H-I, Adjaye J (2016) Modeling nonalcoholic fatty liver disease with human pluripotent stem cell-derived immature hepatocyte-like cells reveals activation of PLIN2 and confirms regulatory functions of peroxisome proliferator-activated receptor alpha. Stem Cells Dev 25:1119\u20131133. https:\/\/doi.org\/10.1089\/scd.2015.0383","journal-title":"Stem Cells Dev"},{"key":"2176_CR31","doi-asserted-by":"publisher","first-page":"46","DOI":"10.1038\/471046a","volume":"471","author":"MF Pera","year":"2011","unstructured":"Pera MF (2011) The dark side of induced pluripotency. Nature 471:46\u201347. https:\/\/doi.org\/10.1038\/471046a","journal-title":"Nature"},{"key":"2176_CR32","doi-asserted-by":"publisher","first-page":"149","DOI":"10.1016\/j.stem.2013.07.001","volume":"13","author":"G Liang","year":"2013","unstructured":"Liang G, Zhang Y (2013) Genetic and epigenetic variations in iPSCs: potential causes and implications for application. Cell Stem Cell 13:149\u2013159. https:\/\/doi.org\/10.1016\/j.stem.2013.07.001","journal-title":"Cell Stem Cell"},{"key":"2176_CR33","doi-asserted-by":"publisher","first-page":"463","DOI":"10.1042\/0264-6021:3490463","volume":"349","author":"W Guo","year":"2000","unstructured":"Guo W, Choi JK, Kirkland JL, Corkey BE, Hamilton JA (2000) Esterification of free fatty acids in adipocytes: a comparison between octanoate and oleate. Biochem J 349:463\u2013471. https:\/\/doi.org\/10.1042\/0264-6021:3490463","journal-title":"Biochem J"},{"key":"2176_CR34","doi-asserted-by":"publisher","first-page":"822","DOI":"10.1016\/j.stemcr.2017.02.015","volume":"8","author":"HS Kruitwagen","year":"2017","unstructured":"Kruitwagen HS, Oosterhoff LA, Vernooij IGWH, Schrall IM, van Wolferen ME, Bannink F, Roesch C, van Uden L, Molenaar MR, Helms JB et al (2017) Long-term adult feline liver organoid cultures for disease modeling of hepatic steatosis. Stem Cell Rep 8:822\u2013830. https:\/\/doi.org\/10.1016\/j.stemcr.2017.02.015","journal-title":"Stem Cell Rep"},{"key":"2176_CR35","doi-asserted-by":"publisher","first-page":"2228","DOI":"10.1136\/gutjnl-2019-319256","volume":"68","author":"N Prior","year":"2019","unstructured":"Prior N, Inacio P, Huch M (2019) Liver organoids: from basic research to therapeutic applications. Gut 68:2228. https:\/\/doi.org\/10.1136\/gutjnl-2019-319256","journal-title":"Gut"},{"key":"2176_CR36","doi-asserted-by":"publisher","first-page":"2142","DOI":"10.1002\/hep.25742","volume":"56","author":"V Nobili","year":"2012","unstructured":"Nobili V, Carpino G, Alisi A, Franchitto A, Alpini G, De Vito R, Onori P, Alvaro D, Gaudio E (2012) Hepatic progenitor cells activation, fibrosis, and adipokines production in pediatric nonalcoholic fatty liver disease. Hepatology 56:2142\u20132153. https:\/\/doi.org\/10.1002\/hep.25742","journal-title":"Hepatology"},{"key":"2176_CR37","doi-asserted-by":"publisher","first-page":"1353","DOI":"10.1002\/hep.20178","volume":"39","author":"S Paku","year":"2004","unstructured":"Paku S, Nagy P, Kopper L, Thorgeirsson SS (2004) 2-acetylaminofluorene dose-dependent differentiation of rat oval cells into hepatocytes: Confocal and electron microscopic studies. Hepatology 39:1353\u20131361. https:\/\/doi.org\/10.1002\/hep.20178","journal-title":"Hepatology"},{"key":"2176_CR38","doi-asserted-by":"publisher","first-page":"350","DOI":"10.1038\/nature23015","volume":"547","author":"A Raven","year":"2017","unstructured":"Raven A, Lu W-Y, Man TY, Ferreira-Gonzalez S, O\u2019Duibhir E, Dwyer BJ, Thomson JP, Meehan RR, Bogorad R, Koteliansky V et al (2017) Cholangiocytes act as facultative liver stem cells during impaired hepatocyte regeneration. Nature 547:350\u2013354. https:\/\/doi.org\/10.1038\/nature23015","journal-title":"Nature"},{"key":"2176_CR39","doi-asserted-by":"publisher","first-page":"115","DOI":"10.3389\/fcell.2020.00115","volume":"8","author":"M Cl\u00e9mot","year":"2020","unstructured":"Cl\u00e9mot M, S\u00eanos Demarco R, Jones DL (2020) Lipid mediated regulation of adult stem cell behavior. Front Cell Dev Biol 8:115. https:\/\/doi.org\/10.3389\/fcell.2020.00115","journal-title":"Front Cell Dev Biol"},{"key":"2176_CR40","doi-asserted-by":"publisher","first-page":"2864","DOI":"10.1634\/stemcells.2007-0308","volume":"25","author":"J Li","year":"2007","unstructured":"Li J, Cui Z, Zhao S, Sidman RL (2007) Unique glycerophospholipid signature in retinal stem cells correlates with enzymatic functions of diverse long-chain acyl-CoA synthetases. Stem Cells 25:2864\u20132873. https:\/\/doi.org\/10.1634\/stemcells.2007-0308","journal-title":"Stem Cells"},{"key":"2176_CR41","doi-asserted-by":"publisher","first-page":"2144","DOI":"10.1016\/j.celrep.2017.08.029","volume":"20","author":"M Knobloch","year":"2017","unstructured":"Knobloch M, Pilz G-A, Ghesqui\u00e8re B, Kovacs WJ, Wegleiter T, Moore DL, Hruzova M, Zamboni N, Carmeliet P, Jessberger S (2017) A fatty acid oxidation-dependent metabolic shift regulates adult neural stem cell activity. Cell Rep 20:2144\u20132155. https:\/\/doi.org\/10.1016\/j.celrep.2017.08.029","journal-title":"Cell Rep"},{"key":"2176_CR42","doi-asserted-by":"publisher","first-page":"901","DOI":"10.1016\/s2213-8587(14)70032-4","volume":"2","author":"H Yki-J\u00e4rvinen","year":"2014","unstructured":"Yki-J\u00e4rvinen H (2014) Non-alcoholic fatty liver disease as a cause and a consequence of metabolic syndrome. Lancet Diabetes Endocrinol 2:901\u2013910. https:\/\/doi.org\/10.1016\/s2213-8587(14)70032-4","journal-title":"Lancet Diabetes Endocrinol"},{"key":"2176_CR43","doi-asserted-by":"publisher","first-page":"27034","DOI":"10.1038\/srep27034","volume":"6","author":"KC Yang","year":"2016","unstructured":"Yang KC, Hung H-F, Lu C-W, Chang H-H, Lee L-T, Huang K-C (2016) Association of non-alcoholic fatty liver disease with metabolic syndrome independently of central obesity and insulin resistance. Sci Rep 6:27034. https:\/\/doi.org\/10.1038\/srep27034","journal-title":"Sci Rep"},{"key":"2176_CR44","doi-asserted-by":"publisher","first-page":"1079","DOI":"10.1111\/j.1478-3231.2012.02775.x","volume":"32","author":"KA Lockman","year":"2012","unstructured":"Lockman KA, Baren JP, Pemberton CJ, Baghdadi H, Burgess KE, Plevris-Papaioannou N, Lee P, Howie F, Beckett G, Pryde A et al (2012) Oxidative stress rather than triglyceride accumulation is a determinant of mitochondrial dysfunction in in vitro models of hepatic cellular steatosis. Liver Int 32:1079\u20131092. https:\/\/doi.org\/10.1111\/j.1478-3231.2012.02775.x","journal-title":"Liver Int"},{"key":"2176_CR45","doi-asserted-by":"publisher","first-page":"1877","DOI":"10.1136\/gutjnl-2019-319104","volume":"69","author":"J-F Dufour","year":"2020","unstructured":"Dufour J-F, Caussy C, Loomba R (2020) Combination therapy for non-alcoholic steatohepatitis: rationale, opportunities and challenges. Gut 69:1877. https:\/\/doi.org\/10.1136\/gutjnl-2019-319104","journal-title":"Gut"},{"key":"2176_CR46","doi-asserted-by":"publisher","first-page":"2184","DOI":"10.1016\/S0140-6736(19)33041-7","volume":"394","author":"ZM Younossi","year":"2019","unstructured":"Younossi ZM, Ratziu V, Loomba R, Rinella M, Anstee QM, Goodman Z, Bedossa P, Geier A, Beckebaum S, Newsome PN et al (2019) Obeticholic acid for the treatment of non-alcoholic steatohepatitis: interim analysis from a multicentre, randomised, placebo-controlled phase 3 trial. Lancet 394:2184\u20132196. https:\/\/doi.org\/10.1016\/S0140-6736(19)33041-7","journal-title":"Lancet"},{"key":"2176_CR47","doi-asserted-by":"publisher","DOI":"10.1016\/j.phrs.2020.104799","volume":"159","author":"M Jalali","year":"2020","unstructured":"Jalali M, Rahimlou M, Mahmoodi M, Moosavian SP, Symonds ME, Jalali R, Zare M, Imanieh MH, Stasi C (2020) The effects of metformin administration on liver enzymes and body composition in non-diabetic patients with non-alcoholic fatty liver disease and\/or non-alcoholic steatohepatitis: An up-to date systematic review and meta-analysis of randomized controlled trials. Pharmacol Res 159:104799. https:\/\/doi.org\/10.1016\/j.phrs.2020.104799","journal-title":"Pharmacol Res"}],"container-title":["Journal of Molecular Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-021-02176-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s00109-021-02176-x\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s00109-021-02176-x.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2022,2,14]],"date-time":"2022-02-14T17:17:44Z","timestamp":1644859064000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s00109-021-02176-x"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2022,1,20]]},"references-count":47,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2022,3]]}},"alternative-id":["2176"],"URL":"https:\/\/doi.org\/10.1007\/s00109-021-02176-x","relation":{},"ISSN":["0946-2716","1432-1440"],"issn-type":[{"value":"0946-2716","type":"print"},{"value":"1432-1440","type":"electronic"}],"subject":[],"published":{"date-parts":[[2022,1,20]]},"assertion":[{"value":"12 July 2021","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"17 December 2021","order":2,"name":"revised","label":"Revised","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 December 2021","order":3,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 January 2022","order":4,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Declarations"}},{"value":"The experiment used of liver tissues for organoids research was approved by the Medical Ethical Council of the Erasmus MC ((MEC2006-202) and patient informed consent was given.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Ethical approval and consent to participate"}},{"value":"The authors declare no competing interests.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Competing interests"}}]}}